Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 108
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.01-029 - NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases
Author(s): Ernest Nadal- Abstract
Loading...
-
+
EP14.01 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
- Presentations: 23
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP14.01-015 - IMforte: A Phase III Study of Lurbinectedin and Atezolizumab Versus Atezolizumab as Maintenance Therapy in ES-SCLC
Author(s): Luis Paz-Ares- Abstract
Loading... -
+
EP14.01-020 - Trial in Progress: [177Lu]Lu-DOTA-TATE Combination Therapy in Treatment-Naïve Extensive Stage Small Cell Lung Cancer
Author(s): Stephen V. Liu- Abstract
Loading...
-
+
EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- Presentations: 46
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP16.03-011 - The European Program for ROutine Testing of Patients with Advanced Lung Cancer (EPROPA) 1 Year Activity
Author(s): Francesco Passiglia- Abstract
Loading...
-
+
OA02 - From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Treatment
- Type: Oral
- Track: Locally Advanced Non-small Cell Lung Cancer
- Presentations: 9
- Moderators:Isabelle Opitz
- Coordinates: 8/07/2022, 12:00 - 13:00, Hall C7
-
+
Session Moderator
12:00 - 12:00 | Author(s): Luis Paz-Ares
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Author(s): Isabelle Opitz
- Abstract
Loading... -
+
OA02.01 - Session Introduction
12:00 - 12:01 | Author(s): Isabelle Opitz
- Abstract
Loading... -
+
OA02.03 - Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-complete Pathological Responders from NADIM Trial
12:02 - 12:12 | Author(s): Marta Casarrubios
- Abstract
Loading... -
+
OA02.02 - Session Introduction
12:01 - 12:02 | Author(s): Luis Paz-Ares
- Abstract
Loading... -
+
OA02.05 - Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study
12:22 - 12:32 | Author(s): Yi-Long Wu
- Abstract
Loading... -
+
OA02.04 - Multimodal Management of T4 N2 Non-small-cell Lung Cancer with Additional Ipsilateral Pulmonary Nodules
12:12 - 12:22 | Author(s): Arvind Kumar
- Abstract
Loading... -
+
OA02.06 - Discussant
12:32 - 12:42 | Author(s): Linda Martin
- Abstract
Loading... -
+
OA02.07 - Live Q&A
12:42 - 13:00
- Abstract
Loading...
-
+
OA03 - Molecular Targeted Treatments
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 11
- Moderators:Andrew Ciupek
- Coordinates: 8/07/2022, 14:30 - 15:40, Hall C7
-
+
OA03.04 - Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
14:42 - 14:52 | Author(s): Adrian Sacher
- Abstract
Loading...
-
+
MA05 - Immune Landscape and Molecular Profiling of Lung Cancer
- Type: Mini Oral
- Track: Tumor Biology and Biomarkers
- Presentations: 13
- Moderators:Luis Paz-Ares
- Coordinates: 8/07/2022, 15:45 - 16:45, Hall C8
-
+
MA05.01 - Session Introduction
15:45 - 15:46 | Author(s): Luis Paz-Ares
- Abstract
Loading... -
+
Session Moderator
15:45 - 15:45 | Author(s): Luis Paz-Ares
- Abstract
Loading... -
+
Session Moderator
15:45 - 15:45 | Author(s): Tina Cascone
- Abstract
Loading... -
+
MA05.02 - Session Introduction
15:46 - 15:47 | Author(s): Tina Cascone
- Abstract
Loading... -
+
MA05.03 - Utilization of Genomic Mutation Signature to Predict the Immunotherapy Response in Non-small Cell Lung Cancer
15:47 - 15:52 | Author(s): Xiaoxuan Wu
- Abstract
Loading... -
+
MA05.04 - Multiplex Phenotyping Reveals Spatial Immune Patterns in NSCLC
15:52 - 15:57 | Author(s): Max Wilhelm Backman
- Abstract
Loading... -
+
MA05.05 - Analysis of CREBBP as a Potential Biomarker for Immune Checkpoint Therapy in Solid Tumors and Its Correlation With Immune Microenvironment
15:57 - 16:02 | Author(s): Xiaoli Liu
- Abstract
Loading... -
+
MA05.07 - Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer With MET Exon 14 Skipping
15:57 - 16:02 | Author(s): Yuchen Han
- Abstract
Loading... -
+
MA05.06 - Discussant
16:02 - 16:12 | Author(s): Fabio Pagni
- Abstract
Loading... -
+
MA05.08 - MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History
16:17 - 16:22 | Author(s): Jennifer A. Marks
- Abstract
Loading... -
+
MA05.09 - Genomic Mapping of Metastatic Organotropism: Analysis of 2326 Primary and Organ-Specific Metastases in Lung Adenocarcinoma
16:22 - 16:27 | Author(s): Harry Lengel
- Abstract
Loading... -
+
MA05.10 - Discussant
16:27 - 16:37 | Author(s): Giulia Pasello
- Abstract
Loading... -
+
MA05.11 - Live Q&A
16:37 - 16:45
- Abstract
Loading...
-
+
P1.16 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 4
- Coordinates: 8/07/2022, 17:00 - 19:00, Exhibit Hall - Hall B
-
+
P1.16-04 - Phase 3 EVOKE-01 Study of Sacituzumab Govitecan vs Docetaxel in NSCLC After Prior Platinum and Checkpoint Inhibitors
Author(s): Niels Reinmuth- Abstract
Loading...
-
+
OA12 - Novel and Combination Strategies for SCLC
- Type: Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Presentations: 10
- Moderators:Alessandra Curioni-Fontecedro
- Coordinates: 8/08/2022, 16:00 - 17:00, Hall C8
-
+
OA12.05 - Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer
16:22 - 16:32 | Author(s): Hossein Borghaei
- Abstract
Loading...
-
+
P2.07 - Pathology - Tumour Genomics
- Type: Regular Poster
- Track: Pathology - Tumour Genomics
- Presentations: 2
- Coordinates: 8/08/2022, 17:15 - 19:15, Exhibit Hall - Hall B
-
+
P2.07-02 - RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC
Author(s): Susana Hernandez- Abstract
Loading...
-
+
MA13 - Update on ROS1 Inhibitors and New Pathways
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 13
- Moderators:Lorenza Landi
- Coordinates: 8/09/2022, 12:00 - 13:00, Hall C7
-
+
MA13.07 - TROPION-Lung02: Initial Results for Datopotamab Deruxtecan Plus Pembrolizumab and Platinum Chemotherapy in Advanced NSCLC
12:27 - 12:32 | Author(s): Benjamin Levy
- Abstract
Loading...
